CMRX - Chimerix Inc
IEX Last Trade
0.947
0.006 0.634%
Share volume: 123,402
Last Updated: Fri 30 Aug 2024 09:56:29 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.94
0.01
0.64%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-03 | 2023-03-02 | 2023-05-04 | 2023-08-03 | 2023-11-02 | 2024-02-29 | 2024-05-01 | |
| Assets | |||||||||
| Total Assets | 53.563 M | 293.880 M | 279.341 M | 258.533 M | 241.085 M | 225.282 M | 212.774 M | 194.042 M | |
| Current Assets | 50.770 M | 291.120 M | 228.138 M | 224.750 M | 211.517 M | 200.622 M | 189.110 M | 163.032 M | |
| Inventories | 4.126 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 3.853 M | 6.022 M | 9.121 M | 9.330 M | 5.735 M | 6.136 M | 5.135 M | 4.003 M | |
| Short Term Investments | 3.853 M | 6.022 M | 9.121 M | 9.330 M | 5.735 M | 6.136 M | 5.135 M | 4.003 M | |
| Total Receivables | 0.000 | 468.000 K | 1.683 M | 668.000 K | 26.000 K | 11.000 K | 1.140 M | 1.000 K | |
| Current Cash | 42.791 M | 284.630 M | 217.334 M | 214.752 M | 205.756 M | 194.475 M | 182.835 M | 159.028 M | |
| Total Non-current Assets | 2.793 M | 2.760 M | 51.203 M | 33.783 M | 29.568 M | 24.660 M | 23.664 M | 31.010 M | |
| Property Plant Equipment | 205.000 K | 252.000 K | 227.000 K | 267.000 K | 256.000 K | 248.000 K | 224.000 K | 263.000 K | |
| Other Assets | 399.000 K | 430.000 K | 386.000 K | 346.000 K | 326.000 K | 292.000 K | 301.000 K | 260.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 53.563 M | 293.880 M | 279.341 M | 258.533 M | 241.085 M | 225.282 M | 212.774 M | 194.042 M | |
| Total liabilities | 25.635 M | 19.928 M | 22.484 M | 18.222 M | 16.973 M | 16.979 M | 19.745 M | 19.940 M | |
| Total current liabilities | 23.271 M | 17.710 M | 20.415 M | 16.431 M | 15.341 M | 15.510 M | 18.443 M | 18.935 M | |
| Accounts Payable | 1.743 M | 3.282 M | 3.034 M | 2.847 M | 1.823 M | 2.502 M | 2.851 M | 3.823 M | |
| Other liabilities | 0.000 | 0.000 | 250.000 K | 125.000 K | 125.000 K | 125.000 K | 125.000 K | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 250.000 K | 250.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 250.000 K | 125.000 K | 125.000 K | 125.000 K | 125.000 K | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 27.928 M | 273.952 M | 256.857 M | 240.311 M | 224.112 M | 208.303 M | 193.029 M | 174.102 M | |
| Common stock | 87.436 M | 87.635 M | 88.061 M | 88.295 M | 88.584 M | 88.621 M | 88.917 M | 89.259 M | |
| Retained earnings | -933.831 M | -692.469 M | -713.429 M | -734.801 M | -753.377 M | -777.363 M | -795.524 M | -817.393 M |